TScan Therapeutics, Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:TCRX) | MetaTrader

Tam grafiği aç Full chart

Haberler

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

H.C. Wainwright, Tscan hissesi için Al tavsiyesini yineledi

TScan Therapeutics finans başkan yardımcısının istifasını açıkladı

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

Tscan Therapeutics kazancı $0,09 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Tscan Therapeutics earnings beat by $0.09, revenue topped estimates

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates

TScan deneme kohort kaydını tamamladı, FDA onayı aldı

TScan completes enrollment in trial cohort, receives FDA clearance

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?